Browse studies

Find your next paid study

1 recruiting study matching your filters

Epcoritamab in Combination With Dose Adjusted R-EPOCH for High Risk Burkitt Lymphoma (BL) (BEDROCK Study)

This phase II trial studies how well epcoritamab works in combination with the chemotherapy regimen dose adjusted etoposide, prednisone, Oncovin (vincristine),…

Adult Burkitt Lymphoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AIDS Malignancy ConsortiumNCT07662928